Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
A08A ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
A08AB Peripherally acting antiobesity products
A08AB01 Orlistat
D04028 Orlistat (JAN/USP/INN) <US>
USP drug classification [BR:br08302]
Anti-Obesity Agents
Orlistat
D04028 Orlistat (JAN/USP/INN)
Risk category of Japanese OTC drugs [BR:br08312]
Drugs requiring guidance
New approved switch OTC drugs
Orlistat
D04028 Orlistat (JAN/USP/INN)
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Carboxylic-ester hydrolases
LIPF
D04028 Orlistat (JAN/USP/INN) <US>
PNLIP
D04028 Orlistat (JAN/USP/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D04028
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D04028
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D04028
Rx-to-OTC switch list in the USA [br08315.html]
D04028